Sinopharm
1099.HK
#1778
Rank
$8.74 B
Marketcap
$2.89
Share price
2.96%
Change (1 day)
5.47%
Change (1 year)
The Sinopharm Group is a Chinese pharmaceutical company that researches, develops, produces, sells and markets pharmaceuticals and other health products.

Sinopharm (1099.HK) - Total liabilities

Total liabilities on the balance sheet as of June 2023 : $42.00 B

According to Sinopharm's latest financial reports the company's total liabilities are $42.00 B. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Sinopharm - Total liabilities on balance sheet (from 2008 to 2023)

Total liabilities by year

Year Total liabilities Change
2022-12-31$36.93 B-0.18%
2021-12-31$36.99 B9.05%
2020-12-31$33.92 B22.84%
2019-12-31$27.62 B13.41%
2018-12-31$24.35 B33.97%
2017-12-31$18.17 B11.53%
2016-12-31$16.29 B8.22%
2015-12-31$15.06 B0.96%
2014-12-31$14.91 B17.48%
2013-12-31$12.69 B38.63%
2012-12-31$9.15 B21.85%
2011-12-31$7.51 B82.08%
2010-12-31$4.12 B78.78%
2009-12-31$2.30 B23.82%
2008-12-31$1.86 B16.56%
2007-12-31$1.59 B38.75%
2006-12-31$1.15 B